Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Laryngeal Diseases 1Hyperphagia 1Carcinoma, Squamous Cell 1

Interventions

Cetuximab 3N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Cisplatin 2capmatinib 1Surveys and Questionnaires 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Adjuvant 1Radiotherapy 1Proflavine 1Modafinil 1Minocycline 1Laryngectomy 1Interviews as Topic 1Emulsions 1Chemoradiotherapy 1Bupropion 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Laryngeal Diseases × Emulsions × Clear all
NCT02236936 2020-05-01

AGMT_HNO_PN

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 3 Terminated
8 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Hyperphagia, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡